Articles

PVRIG is a novel NK cell immune checkpoint receptor in acute myeloid leukemia

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne
Compugen, USA, Inc., South San Francisco, California
Compugen, USA, Inc., South San Francisco, California
Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Université de Paris, Inserm, U976 HIPI Unit, Institut de Recherche Saint-Louis, Paris
Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne
Compugen, USA, Inc., South San Francisco, California
Compugen, USA, Inc., South San Francisco, California
Compugen, USA, Inc., South San Francisco, California
Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne
Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne
Haematologica Early view Nov 5, 2020 https://doi.org/10.3324/haematol.2020.258574